Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus

Dengue virus (DENV) presents a significant threat to global public health with more than 500,000 hospitalizations and 25,000 deaths annually. Currently, there is no clinically approved antiviral drug to treat DENV infection. The envelope (E) glycoprotein of DENV is a promising target for drug discov...

Full description

Saved in:
Bibliographic Details
Published in:Viruses
Main Authors: Anasir, Mohd Ishtiaq, Ramanathan, Babu, Poh, Chit Laa
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7232406/
https://ncbi.nlm.nih.gov/pubmed/32225021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v12040367
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items